Profile data is unavailable for this security.
About the company
SYBLEU Inc. is engaged in the acquisition, licensing and development of medical and veterinary applications. The Company is focused on developing therapies for human and animal health, medical devices, and clinical diagnostics. The Company is also developing drugs for treating cancer in companion animals and examining the role of artificial intelligence and machine learning in clinical diagnostics. It is also involved in the development of disposable medical devices. It has completed Phase I and or Phase II clinical trials after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials.
- Revenue in USD (TTM)11.70k
- Net income in USD-307.88k
- Incorporated2020
- Employees--
- LocationSYBLEU Inc1034 Throggs Neck ExpresswayBRONX 10465United StatesUSA
- Phone+1 (718) 795-7790
- Websitehttps://sybleu.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt PLC | 1.91bn | -1.49bn | 1.60m | 2.80k | -- | -- | -- | 0.0008 | -161.65 | -161.63 | 89.63 | 55.44 | 0.4062 | 1.57 | 4.94 | 681,821.40 | -31.61 | -12.49 | -36.10 | -15.85 | 26.22 | 35.68 | -77.83 | -44.38 | 1.63 | -0.3456 | 0.6164 | -- | -2.53 | -10.31 | -83.00 | -- | -- | -- |
Stemcell Holdings Inc | 9.98m | 3.10m | 1.64m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
SOHM Inc | -100.00bn | -100.00bn | 1.66m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Procyon Corp | 4.70m | -314.48k | 1.70m | 17.00 | -- | 0.7633 | -- | 0.3614 | -0.0388 | -0.0388 | 0.5804 | 0.2901 | 1.40 | 1.95 | 8.58 | 276,481.20 | -8.90 | 3.52 | -10.60 | 4.23 | 77.60 | 73.30 | -6.35 | 2.52 | 2.70 | -- | 0.00 | -- | -3.22 | 3.11 | 70.44 | -- | 30.98 | -- |
InVitro International | 716.89k | 6.22k | 1.71m | 16.00 | 214.29 | 2.33 | -- | 2.38 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
PainReform Ltd | 0.00 | -12.54m | 1.73m | 6.00 | -- | 0.7009 | -- | -- | -7.77 | -7.77 | 0.00 | 0.9988 | 0.00 | -- | -- | 0.00 | -158.88 | -55.47 | -222.89 | -68.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.28 | -- | -- | -- |
Panbela Therapeutics Inc | 0.00 | -27.26m | 1.75m | 7.00 | -- | -- | -- | -- | -20.38 | -20.38 | 0.00 | -0.6563 | 0.00 | -- | -- | 0.00 | -201.94 | -215.89 | -809.38 | -476.38 | -- | -- | -- | -- | -- | -161.79 | 4.16 | -- | -- | -- | 27.68 | -- | -- | -- |
SYBLEU Inc | 11.70k | -307.88k | 1.84m | -- | -- | -- | -- | 157.17 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
Link Reservations Inc | 0.00 | -480.90k | 1.85m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
Qualigen Therapeutics Inc | 0.00 | -12.48m | 1.92m | 4.00 | -- | -- | -- | -- | -2.46 | -2.64 | 0.00 | -0.3923 | 0.00 | -- | -- | 0.00 | -118.15 | -- | -364.72 | -- | 21.30 | -- | -- | -- | -- | -7.41 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
CanaQuest Medical Corp | 0.00 | -806.00k | 1.93m | -- | -- | -- | -- | -- | -0.0513 | -0.0513 | 0.00 | -0.0370 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
Twinlab Consolidated Holdings Inc | 12.65m | -9.55m | 1.94m | 17.00 | -- | -- | -- | 0.1537 | -0.0369 | -0.0502 | 0.0488 | -0.5447 | 1.01 | 1.49 | 7.30 | 743,941.20 | -76.13 | -60.53 | -- | -- | 34.59 | 21.36 | -75.51 | -37.72 | 0.0094 | -0.0108 | -- | -- | -20.87 | -28.58 | -20.28 | -- | -- | -- |
Applied DNA Sciences Inc | 5.52m | -12.50m | 1.96m | 53.00 | -- | -- | -- | 0.3551 | -17.13 | -17.13 | 7.67 | -0.0558 | 0.3893 | 10.38 | 4.64 | 104,110.80 | -87.15 | -88.57 | -111.09 | -121.91 | 33.98 | 44.35 | -223.89 | -113.26 | 1.54 | -- | -- | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
Target Group Inc | 5.64m | 228.87k | 1.97m | 46.00 | 24.62 | -- | 1.86 | 0.3501 | 0.0001 | 0.0001 | 0.0088 | -0.0115 | 0.764 | 8.60 | 124.27 | 115,104.10 | 3.10 | -37.99 | -- | -78.76 | 43.71 | -- | 4.06 | -586.97 | 0.0736 | 0.0149 | 3.10 | -- | -- | 577.83 | 92.84 | -- | -58.54 | -- |
CYANOTECH CORP | 22.49m | -4.62m | 1.98m | 86.00 | -- | 0.1419 | -- | 0.088 | -0.7265 | -0.7265 | 3.53 | 2.01 | 0.7889 | 1.53 | 10.73 | 261,546.50 | -16.19 | -2.32 | -21.07 | -2.96 | 29.59 | 35.88 | -20.52 | -2.33 | 0.3702 | -5.93 | 0.3299 | -- | -35.56 | -7.44 | -259.70 | -- | 1.22 | -- |
Data as of May 22 2024. Currency figures normalised to SYBLEU Inc's reporting currency: US Dollar USD